Topic
Liver Cancer
37 Podcasts • 19 Cases • 4 Courses on BackTable
Hear how experienced physicians manage Liver Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 642 • 07 May 2026
Exploring CPN & Radiation Segmentectomy in Liver Cancer
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is cracking the code on complete tumor kill in hepatocellular carcinoma (HCC) bridging therapy. Host Dr. Kavi Krishnasamy is joined by Dr. Zach Berman and Dr. Beau Toskich to break down the latest multi-center research from COBRAS (Consortium on Bridging Radiation Segementectomy with Glass Microspheres Before Transplant), setting a new standard for bridging therapy that offers actionable strategies to improve outcomes.
More on Liver Cancer
Loading recent podcasts…
VI Episode #642
May 7, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
VI Episode #641
May 5, 2026
with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow
With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...
VI Episode #639
Apr 30, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes, Dr. Venkatesh Krishnasamy
Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence?...
20+ listens
VI Episode #592
Nov 25, 2025
with Dr. Jason Hoffmann, Dr. Sabeen Dhand
With the range of interventional modalities that are available for metastatic liver tumors, when should you advocate...
1,700+ listens
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
VI Episode #640
May 1, 2026
with Dr. Maarten Smits, Dr. Venkatesh Krishnasamy
When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In...
700+ listens
VI Episode #632
Apr 8, 2026
with Dr. Riad Salem, Dr. Tyler Sandow, Dr. Juan Gimenez
You may know him as the godfather of Y90, but you might not know what it took for Dr. Riad Salem to earn that title....
100+ listens
VI Episode #577
Sep 30, 2025
with Dr. Driss Raissi, Dr. Christopher Beck
Is microwave ablation only for simple liver tumors, or can it be a versatile ‘Swiss Army knife’ for a wide range of...
2,000+ listens
VI Case
Apr 9, 2026
with Dr. Riad Salem, Dr. Neil Mehta and Dr. Tyler Sandow
VI Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
VI Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
VI Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
VI Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
VI Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
VI Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
VI Case
Jan 22, 2025
with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.